Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT01123421
Study to demonstrate that the Bone UltraSonic Scanner (BUSS) can aid in detection of osteoporosis and predict prevalent osteoporotic fractures. Measurements derived from the BUSS parameters will be able to discriminate between postmenopausal women with osteoporotic fractures when compared to matched controls without history of osteoporotic fracture.
Looking for future studies?
Notify MeFemale
Observational
Rochester, Minnesota, 55905, United States
One of several studies to develop and clinically validate a novel ultrasonographic device, BUSS, for the assessment of osteoporosis and fracture risk.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1 year
Artann Laboratories
Industry
Portable Ultrasonometer for Osteoporosis Assessment: Retrospective Fracture Risk Validation Study, Version #1
Acronym: BUSS03
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05445336
Bone Diseases, Bone Diseases, Metabolic
Hamilton, Ontario, Canada
View Trial DetailsNCT00697463
Bone Diseases, Bone Diseases, Metabolic
Omaha, Nebraska, United States
View Trial DetailsNCT02608749
Bone Diseases, Bone Diseases, Metabolic
Taipei, Taiwan
View Trial DetailsNCT01049191
Bone Diseases, Bone Diseases, Metabolic
Madison, Wisconsin, United States
View Trial Details